Mereo BioPharma Group plc MREO Q1 2026 Earnings NarrowerThanExpected Loss Drives Modest Stock Uplift Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues Business First Bancshares Inc BFST Q1 2026 Earnings EPS Beats Estimates by 42 as Shares Slip ATT Q1 2026 Earnings EPS Slightly Beats Estimates Stock Edges Lower ALKS Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise Organon OGN Holds Steady Near Support Level After Modest Gain Cato Corporation CATO Edges Higher as Stock Tests Key Resistance Levels Eagle Materials EXP Surges 358 as Construction Demand Lifts Cement Sector Halozyme Therapeutics HALO Rises Modestly Support and Resistance Levels in Focus Crown Crafts Inc CRWS Q1 2026 Earnings Earnings Beat With EPS of 014 Despite Sparse Disclosures